CUREXO secures 8.45B KRW robot surgery contract
큐렉소
060280
Signal Score
Historical Avg Return (5d)
+0.15%
Data Coverage
100%n=723
Risk-adjusted indicator based on 723 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
POSITIVE
Key Numbers
- • Contract Amount: 8,456,625,000 KRW
- • Percentage of Recent Revenue: 11.4%
- • Contract Product: CUVIS-joint artificial joint surgery robot
- • Contract Period: May 19, 2026 to December 31, 2026
- • Recent Revenue (2025): 74,531,816,400 KRW
AI Analysis Summary
CUREXO, INC. announced a sales and supply contract worth 8,456,625,000 KRW (USD 5,625,000.00) for its CUVIS-joint artificial joint surgery robot with Biorad Medisys Pvt. Ltd. in India. This contract represents 11.4% of CUREXO's recent annual revenue of 74,531,816,400 KRW (2025 consolidated financial statements). The contract period is from May 19, 2026, to December 31, 2026. This significant contract is expected to have a positive impact on future revenue and market expansion in India.
How This Event Is Evaluated
Strategic Contract Evaluation
Contract events are evaluated by measuring business scale, revenue relevance, counterparty quality, and execution visibility.
AI is used to interpret disclosures and extract structured data.
Signal scores are generated using event-specific methodologies and quantitative models.
- Contract size relative to company revenue
- Expected revenue impact
- Counterparty quality
- Contract duration and execution period
Track Korean Market Signals — Free
Sign up free to access live disclosures, AI analysis, and event filters.
Public Beta · No credit card required
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.